Hepatocellular carcinoma after direct-acting antiviral therapy for chronic HCV infection: Is it a real risk?

The newer oral treatments for chronic hepatitis C virus infection are one of the greatest revolutions in modern medicine. These drugs promise to eradicate the infection, showing high cure rates even in difficult to treat populations with very few side effects. Nevertheless, some cases of recurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Cátia, Duarte-Ribeiro, Filipa, Pipa, Sara, Barbosa, Ana Rita, Mota, Margarida, Rosas Vieira, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125765/
https://www.ncbi.nlm.nih.gov/pubmed/30191133
http://dx.doi.org/10.1016/j.idcr.2018.e00450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125765/
https://www.ncbi.nlm.nih.gov/pubmed/30191133
http://dx.doi.org/10.1016/j.idcr.2018.e00450

Ejemplares similares